Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 177 | 806 | 1,583 | 1,957 | 2,055 |
| Gross Profit | 177 | 806 | 1,583 | 1,957 | 2,055 |
| Operating Expenses | 19,220 | 18,441 | 20,288 | 19,850 | 14,658 |
| Operating Income | -19,043 | -17,635 | -18,705 | -17,893 | -12,603 |
| Interest Expense | 46 | 52 | 62 | 71 | 70 |
| Other Income | 802 | 1,307 | 1,729 | 1,919 | 1,920 |
| Pre-tax Income | -18,287 | -16,380 | -17,038 | -16,045 | -10,753 |
| Net Income Continuous | -18,287 | -16,380 | -17,038 | -16,045 | -10,753 |
| Net Income | $-18,287 | $-16,380 | $-17,038 | $-16,045 | $-10,753 |
| EPS Basic Total Ops | -0.49 | -0.44 | -0.46 | -0.43 | -0.29 |
| EPS Basic Continuous Ops | -0.49 | -0.44 | -0.46 | -0.43 | -0.29 |
| EPS Diluted Total Ops | -0.49 | -0.44 | -0.46 | -0.43 | -0.29 |
| EPS Diluted Continuous Ops | -0.49 | -0.44 | -0.46 | -0.43 | -0.29 |
| EBITDA(a) | $-18,528 | $-17,472 | $-17,961 | $-17,894 | $-12,983 |